These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels. Ang G, Feiglin D, Moses AM. Endocr Pract; 2003; 9(4):280-3. PubMed ID: 14561571 [Abstract] [Full Text] [Related]
5. Intravenously administered pamidronate in the treatment of Paget's disease of bone. Tucci JR, Bontha S. Endocr Pract; 2001; 7(6):423-9. PubMed ID: 11747277 [Abstract] [Full Text] [Related]
10. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates. Alvarez L, Peris P, Guañabens N, Vidal S, Ros I, Pons F, Filella X, Monegal A, Muñoz-Gomez J, Ballesta AM. Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438 [Abstract] [Full Text] [Related]
19. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline. Muschitz C, Feichtinger X, Haschka J, Kocijan R. Wien Med Wochenschr; 2017 Feb; 167(1-2):18-24. PubMed ID: 27600563 [Abstract] [Full Text] [Related]